Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
785,87 B | 23,56% | 6/6 | 34,75% | 19,63% | 43,47% | DOWN |
|
Johnson & Johnson NYSE:JNJ |
579,15 B | 5,27% | 5/5 | 6,91% | -31,78% | 1,89% | UP |
|
Merck NYSE:MRK |
295,77 B | 7,67% | 6/6 | -21,36% | -9,57% | 10,34% | UP |
|
Pfizer NYSE:PFE |
153,81 B | 7,82% | 4/6 | -5,31% | 21,90% | -0,15% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
119,52 B | 1,77% | 5/6 | -0,30% | -0,63% | 9,33% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
110,02 B | 13,44% | 6/6 | 6,43% | -0,47% | 28,85% | DOWN |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
75,70 B | 9,26% | 5/6 | 5,41% | 6,02% | 18,61% | UP |
|
Zoetis NYSE:ZTS |
47,85 B | 9,80% | 6/6 | 7,18% | 49,14% | 27,92% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
22,91 B | 15,13% | 5/6 | 2,36% | -21,15% | 16,19% | UP |
|
Viatris NasdaqGS:VTRS |
15,03 B | -3,69% | 4/6 | 2,81% | -37,09% | 30,27% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
11,72 B | 0,00% | 2/4 | 0,00% | 0,00% | 25,71% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Cytokinetics NasdaqGS:CYTK |
7,70 B | -1,08% | 1/6 | 4,92% | -37,33% | 44,00% | UP |
|
Balchem NasdaqGS:BCPC |
5,35 B | 8,75% | 6/6 | 8,46% | 4,39% | 21,29% | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
3,75 B | 28,91% | 5/6 | 11,94% | -12,49% | 19,80% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
4,69 B | 63,45% | 3/5 | 33,54% | 93,39% | 44,88% | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
4,00 B | 10,36% | 5/6 | 124,19% | 20,30% | 59,57% | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
3,90 B | 7,83% | 5/6 | 3,41% | -55,16% | 23,54% | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,85 B | 2,48% | 3/6 | 8,34% | -23,57% | 31,26% | UP |
|
Endo OTCPK:NDOI |
1,80 B | 3,65% | 0/5 | 61,08% | 23,81% | -100,00% | DOWN |
